(Q38844981)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381243%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

Applying CRISPR-Cas9 tools to identify and characterize transcriptional enhancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381243%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381243%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Reuven Agami

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381243%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Rui Lopes

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381243%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

publication date

6 July 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381243%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Molecular Cell Biology

17 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381243%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381243%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381243%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

597-604

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27381243%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrm.2016.79

17 March 2020

exact match

0 references

cites work

Expression of a β-globin gene is enhanced by remote SV40 DNA sequences

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Enhancers: the abundance and function of regulatory sequences beyond promoters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Systematic localization of common disease-associated variation in regulatory DNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

An atlas of active enhancers across human cell types and tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

The accessible chromatin landscape of the human genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Genomic views of distant-acting enhancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Multiplex genome engineering using CRISPR/Cas systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

RNA-programmed genome editing in human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

RNA-guided human genome engineering via Cas9

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

RNA-guided gene activation by CRISPR-Cas9-based transcription factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

CRISPR RNA-guided activation of endogenous human genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

A protein-tagging system for signal amplification in gene expression and fluorescence imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Eukaryotic activators function during multiple steps of preinitiation complex assembly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Sequential recruitment of HAT and SWI/SNF components to condensed chromatin by VP16.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

TALE-mediated modulation of transcriptional enhancers in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Functional annotation of native enhancers with a Cas9-histone demethylase fusion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

The selection and function of cell type-specific enhancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Hormone-responsive enhancer-activity maps reveal predictive motifs, indirect repression, and targeting of closed chromatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Master transcription factors and mediator establish super-enhancers at key cell identity genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

A Sox2 distal enhancer cluster regulates embryonic stem cell differentiation potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

CRISPR reveals a distal super-enhancer required for Sox2 expression in mouse embryonic stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

High-throughput mapping of regulatory DNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

A new class of temporarily phenotypic enhancers identified by CRISPR/Cas9-mediated genetic screening

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Orthogonal Cas9 proteins for RNA-guided gene regulation and editing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Engineered CRISPR-Cas9 nucleases with altered PAM specificities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

In vivo genome editing using Staphylococcus aureus Cas9

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Saturation editing of genomic regions by multiplex homology-directed repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

DNA targeting specificity of RNA-guided Cas9 nucleases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Genetic screens in human cells using the CRISPR-Cas9 system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Genome-scale CRISPR-Cas9 knockout screening in human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

High-throughput functional genomics using CRISPR-Cas9.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Rapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

An integrated encyclopedia of DNA elements in the human genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Optical control of mammalian endogenous transcription and epigenetic states

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Photoactivatable CRISPR-Cas9 for optogenetic genome editing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

CRISPR-Cas9-based photoactivatable transcription system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

A light-inducible CRISPR-Cas9 system for control of endogenous gene activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Mutational heterogeneity in cancer and the search for new cancer-associated genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

CTCF establishes discrete functional chromatin domains at the Hox clusters during differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Activation of proto-oncogenes by disruption of chromosome neighborhoods.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Reactivation of developmentally silenced globin genes by forced chromatin looping.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Genome-wide mapping of in vivo protein-DNA interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

ChIP-seq accurately predicts tissue-specific activity of enhancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Mapping and analysis of chromatin state dynamics in nine human cell types

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

High-resolution mapping and characterization of open chromatin across the genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Capturing chromosome conformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Comprehensive mapping of long-range interactions reveals folding principles of the human genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

An oestrogen-receptor-α-bound human chromatin interactome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Widespread transcription at neuronal activity-regulated enhancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Massively parallel functional dissection of mammalian enhancers in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Genome-wide quantitative enhancer activity maps identified by STARR-seq

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Modification of enhancer chromatin: what, how, and why?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Transcriptional enhancers: from properties to genome-wide predictions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

31 March 2020

Mapping human epigenomes

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Enhancer transcripts mark active estrogen receptor binding sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Microhomology-based choice of Cas9 nuclease target sites.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79

Rationally engineered Cas9 nucleases with improved specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2016.79